91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Global Pet Medication Market Research Report 2023

Global Pet Medication Market Research Report 2023

Publication ID: 
PB504234304
Publication Date: 
April 7, 2023
Pages: 
100
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 2,900.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Healthcare [2]
Pharma & Healthcare [3]
Description: 

Highlights
The global Pet Medication market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Pet Medication is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Pet Medication is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Pet Medication include Zoetis, Merck, Elanco, Bayer, Boehringer, Novartis, Virbac, Ceva and Vetoquinol, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pet Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Medication.
The Pet Medication market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pet Medication market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Medication manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Zoetis
Merck
Elanco
Bayer
Boehringer
Novartis
Virbac
Ceva
Vetoquinol
Nexvet
Aratana Therapeutics
Kindred Biosciences
Ambrx
Entest Biomedical
Taconic Biosciences
Segment by Type
Antibiotics
Antifungal
Flea Products
Segment by Application
Cat
Dog
Horse
Fish
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Pet Medication Market Overview
1.1 Product Overview and Scope of Pet Medication
1.2 Pet Medication Segment by Type
1.2.1 Global Pet Medication Market Value Comparison by Type (2023-2029)
1.2.2 Antibiotics
1.2.3 Antifungal
1.2.4 Flea Products
1.3 Pet Medication Segment by Application
1.3.1 Global Pet Medication Market Value by Application: (2023-2029)
1.3.2 Cat
1.3.3 Dog
1.3.4 Horse
1.3.5 Fish
1.3.6 Others
1.4 Global Pet Medication Market Size Estimates and Forecasts
1.4.1 Global Pet Medication Revenue 2018-2029
1.4.2 Global Pet Medication Sales 2018-2029
1.4.3 Global Pet Medication Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Pet Medication Market Competition by Manufacturers
2.1 Global Pet Medication Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pet Medication Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pet Medication Average Price by Manufacturers (2018-2023)
2.4 Global Pet Medication Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Pet Medication, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet Medication, Product Type & Application
2.7 Pet Medication Market Competitive Situation and Trends
2.7.1 Pet Medication Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pet Medication Players Market Share by Revenue
2.7.3 Global Pet Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet Medication Retrospective Market Scenario by Region
3.1 Global Pet Medication Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Pet Medication Global Pet Medication Sales by Region: 2018-2029
3.2.1 Global Pet Medication Sales by Region: 2018-2023
3.2.2 Global Pet Medication Sales by Region: 2024-2029
3.3 Global Pet Medication Global Pet Medication Revenue by Region: 2018-2029
3.3.1 Global Pet Medication Revenue by Region: 2018-2023
3.3.2 Global Pet Medication Revenue by Region: 2024-2029
3.4 North America Pet Medication Market Facts & Figures by Country
3.4.1 North America Pet Medication Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Pet Medication Sales by Country (2018-2029)
3.4.3 North America Pet Medication Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pet Medication Market Facts & Figures by Country
3.5.1 Europe Pet Medication Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Pet Medication Sales by Country (2018-2029)
3.5.3 Europe Pet Medication Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet Medication Market Facts & Figures by Country
3.6.1 Asia Pacific Pet Medication Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Pet Medication Sales by Country (2018-2029)
3.6.3 Asia Pacific Pet Medication Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pet Medication Market Facts & Figures by Country
3.7.1 Latin America Pet Medication Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Pet Medication Sales by Country (2018-2029)
3.7.3 Latin America Pet Medication Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet Medication Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet Medication Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Pet Medication Sales by Country (2018-2029)
3.8.3 Middle East and Africa Pet Medication Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pet Medication Sales by Type (2018-2029)
4.1.1 Global Pet Medication Sales by Type (2018-2023)
4.1.2 Global Pet Medication Sales by Type (2024-2029)
4.1.3 Global Pet Medication Sales Market Share by Type (2018-2029)
4.2 Global Pet Medication Revenue by Type (2018-2029)
4.2.1 Global Pet Medication Revenue by Type (2018-2023)
4.2.2 Global Pet Medication Revenue by Type (2024-2029)
4.2.3 Global Pet Medication Revenue Market Share by Type (2018-2029)
4.3 Global Pet Medication Price by Type (2018-2029)
5 Segment by Application
5.1 Global Pet Medication Sales by Application (2018-2029)
5.1.1 Global Pet Medication Sales by Application (2018-2023)
5.1.2 Global Pet Medication Sales by Application (2024-2029)
5.1.3 Global Pet Medication Sales Market Share by Application (2018-2029)
5.2 Global Pet Medication Revenue by Application (2018-2029)
5.2.1 Global Pet Medication Revenue by Application (2018-2023)
5.2.2 Global Pet Medication Revenue by Application (2024-2029)
5.2.3 Global Pet Medication Revenue Market Share by Application (2018-2029)
5.3 Global Pet Medication Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Pet Medication Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Zoetis Pet Medication Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Pet Medication Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck Pet Medication Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Elanco
6.3.1 Elanco Corporation Information
6.3.2 Elanco Description and Business Overview
6.3.3 Elanco Pet Medication Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Elanco Pet Medication Product Portfolio
6.3.5 Elanco Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Pet Medication Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bayer Pet Medication Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Boehringer
6.5.1 Boehringer Corporation Information
6.5.2 Boehringer Description and Business Overview
6.5.3 Boehringer Pet Medication Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Boehringer Pet Medication Product Portfolio
6.5.5 Boehringer Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Pet Medication Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Novartis Pet Medication Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Virbac
6.6.1 Virbac Corporation Information
6.6.2 Virbac Description and Business Overview
6.6.3 Virbac Pet Medication Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Virbac Pet Medication Product Portfolio
6.7.5 Virbac Recent Developments/Updates
6.8 Ceva
6.8.1 Ceva Corporation Information
6.8.2 Ceva Description and Business Overview
6.8.3 Ceva Pet Medication Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Ceva Pet Medication Product Portfolio
6.8.5 Ceva Recent Developments/Updates
6.9 Vetoquinol
6.9.1 Vetoquinol Corporation Information
6.9.2 Vetoquinol Description and Business Overview
6.9.3 Vetoquinol Pet Medication Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Vetoquinol Pet Medication Product Portfolio
6.9.5 Vetoquinol Recent Developments/Updates
6.10 Nexvet
6.10.1 Nexvet Corporation Information
6.10.2 Nexvet Description and Business Overview
6.10.3 Nexvet Pet Medication Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Nexvet Pet Medication Product Portfolio
6.10.5 Nexvet Recent Developments/Updates
6.11 Aratana Therapeutics
6.11.1 Aratana Therapeutics Corporation Information
6.11.2 Aratana Therapeutics Pet Medication Description and Business Overview
6.11.3 Aratana Therapeutics Pet Medication Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Aratana Therapeutics Pet Medication Product Portfolio
6.11.5 Aratana Therapeutics Recent Developments/Updates
6.12 Kindred Biosciences
6.12.1 Kindred Biosciences Corporation Information
6.12.2 Kindred Biosciences Pet Medication Description and Business Overview
6.12.3 Kindred Biosciences Pet Medication Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Kindred Biosciences Pet Medication Product Portfolio
6.12.5 Kindred Biosciences Recent Developments/Updates
6.13 Ambrx
6.13.1 Ambrx Corporation Information
6.13.2 Ambrx Pet Medication Description and Business Overview
6.13.3 Ambrx Pet Medication Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Ambrx Pet Medication Product Portfolio
6.13.5 Ambrx Recent Developments/Updates
6.14 Entest Biomedical
6.14.1 Entest Biomedical Corporation Information
6.14.2 Entest Biomedical Pet Medication Description and Business Overview
6.14.3 Entest Biomedical Pet Medication Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Entest Biomedical Pet Medication Product Portfolio
6.14.5 Entest Biomedical Recent Developments/Updates
6.15 Taconic Biosciences
6.15.1 Taconic Biosciences Corporation Information
6.15.2 Taconic Biosciences Pet Medication Description and Business Overview
6.15.3 Taconic Biosciences Pet Medication Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Taconic Biosciences Pet Medication Product Portfolio
6.15.5 Taconic Biosciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet Medication Industry Chain Analysis
7.2 Pet Medication Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet Medication Production Mode & Process
7.4 Pet Medication Sales and Marketing
7.4.1 Pet Medication Sales Channels
7.4.2 Pet Medication Distributors
7.5 Pet Medication Customers
8 Pet Medication Market Dynamics
8.1 Pet Medication Industry Trends
8.2 Pet Medication Market Drivers
8.3 Pet Medication Market Challenges
8.4 Pet Medication Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned: 

Zoetis
Merck
Elanco
Bayer
Boehringer
Novartis
Virbac
Ceva
Vetoquinol
Nexvet
Aratana Therapeutics
Kindred Biosciences
Ambrx
Entest Biomedical
Taconic Biosciences

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-pet-medication-market-research-report-2023

Links
[1] /countries/global[2] /healthcare[3] /pharma-healthcare